National Research Co. (NASDAQ:NRC) Shares Sold by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. lowered its stake in shares of National Research Co. (NASDAQ:NRC) by 13.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 34,318 shares of the company’s stock after selling 5,300 shares during the period. Daiwa Securities Group Inc. owned 0.14% of National Research worth $1,358,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Summit Global Investments raised its position in National Research by 3.8% in the third quarter. Summit Global Investments now owns 8,452 shares of the company’s stock valued at $375,000 after purchasing an additional 310 shares during the period. Cardinal Capital Management raised its position in National Research by 3.0% in the fourth quarter. Cardinal Capital Management now owns 16,525 shares of the company’s stock valued at $656,000 after purchasing an additional 483 shares during the period. Swiss National Bank raised its position in National Research by 1.6% in the third quarter. Swiss National Bank now owns 32,500 shares of the company’s stock valued at $1,442,000 after purchasing an additional 500 shares during the period. Portside Wealth Group LLC raised its position in National Research by 11.9% in the fourth quarter. Portside Wealth Group LLC now owns 5,238 shares of the company’s stock valued at $207,000 after purchasing an additional 555 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in National Research by 184.3% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,179 shares of the company’s stock valued at $126,000 after purchasing an additional 2,061 shares during the period. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Price Performance

NRC stock opened at $34.24 on Wednesday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $816.62 million, a PE ratio of 27.39 and a beta of 0.42. National Research Co. has a 12-month low of $32.08 and a 12-month high of $47.25. The business’s fifty day moving average price is $38.46 and its 200 day moving average price is $39.96.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Tuesday, February 13th. The company reported $0.36 earnings per share (EPS) for the quarter. The firm had revenue of $38.00 million for the quarter. National Research had a return on equity of 47.79% and a net margin of 20.84%.

National Research Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 29th were issued a $0.12 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $0.48 annualized dividend and a dividend yield of 1.40%. National Research’s dividend payout ratio is presently 38.40%.

Analysts Set New Price Targets

Separately, TheStreet downgraded National Research from a “b-” rating to a “c+” rating in a report on Thursday, January 11th.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.